Company profile
Bio Essence Corp CIK 1723059
Ticker
BIOE (OTC)
Industry
Pharmaceutical Preparations
Headquarters
Irvine, CA 92614
Fiscal year end
2025 (FY)
Key Financials
Revenue
$1.90M
Net income
$896.2K
Total assets
$422.5K
Total liabilities
$2.50M
Stockholders' equity
-$2.07M
Cash & equivalents
—
Operating income
$900.0K
Operating cash flow
$1.57M
Capital expenditures
—
Fiscal year 2025, via 10-K filed 2026-03-27. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
47.4%
Net margin
47.2%
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
590.7%
Equity / assets
-490.7%
CapEx / revenue
—
Operating cash flow / net income
1.75×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025
$1.90M
$896.2K
$422.5K
$2.50M
-$2.07M
2024
$323.9K
-$1.31M
$281.0K
$3.25M
-$2.97M
2023
$551.5K
-$971.9K
$2.76M
$4.42M
-$1.66M
2022
$621.6K
-$809.7K
$1.55M
$4.79M
-$3.24M
2021
$888.0K
-$647.6K
$1.70M
$4.13M
-$2.43M
Company Details
SIC code
2834
State of incorporation
CA
Active filer
Yes
Most recent SEC filing
Form 10-Q
2026-08-14
Financials filed via
Form 10-K
filed 2026-03-27
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Irvine, CA 92614
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:18 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.